ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 53 filers reported holding ADC THERAPEUTICS SA in Q1 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,537,152 | -20.4% | 400,300 | -0.0% | 0.00% | -50.0% |
| Q3 2022 | $1,930,000 | -40.2% | 400,400 | -1.4% | 0.00% | 0.0% |
| Q2 2022 | $3,228,000 | -28.0% | 406,102 | +33.0% | 0.00% | -33.3% |
| Q1 2022 | $4,484,000 | -26.8% | 305,246 | +0.7% | 0.00% | -25.0% |
| Q4 2021 | $6,126,000 | -22.7% | 303,234 | +3.9% | 0.00% | -20.0% |
| Q3 2021 | $7,925,000 | +10.3% | 291,805 | -1.1% | 0.01% | 0.0% |
| Q2 2021 | $7,187,000 | +34.1% | 295,163 | +34.5% | 0.01% | +25.0% |
| Q1 2021 | $5,358,000 | -21.4% | 219,499 | +3.1% | 0.00% | -20.0% |
| Q4 2020 | $6,817,000 | -3.6% | 212,974 | -0.7% | 0.01% | -16.7% |
| Q3 2020 | $7,072,000 | -1.3% | 214,380 | +40.0% | 0.01% | 0.0% |
| Q2 2020 | $7,166,000 | – | 153,087 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $4,555,066 | 2.69% |
| Blue Owl Capital Holdings LP | 733,568 | $2,816,901 | 1.20% |
| Redmile Group, LLC | 7,590,849 | $29,148,860 | 1.19% |
| AlphaCentric Advisors LLC | 297,500 | $1,142,400 | 1.13% |
| Prosight Management, LP | 463,310 | $1,779,110 | 0.97% |
| GCM Grosvenor Holdings, LLC | 735,471 | $2,824,209 | 0.72% |
| Indie Asset Partners, LLC | 93,839 | $360,342 | 0.40% |
| XTX Topco Ltd | 197,635 | $758,918 | 0.16% |
| Eventide Asset Management | 1,879,959 | $7,219,043 | 0.14% |
| Nantahala Capital Management | 243,290 | $934,234 | 0.06% |